BioSpace News Archive

Biotech Bay

Avinger Secures Waiver and Consent to CRG Loan Agreement

The PIK loan allows Avinger to conserve cash usage by increasing the principal amount of the loan.

December 15, 2017
·
1 min read
Genetown

Acer Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

Acer intends to use the net proceeds from this offering to fund its research and development efforts, to seek regulatory approval for EDSIVO and more.

December 15, 2017
·
4 min read
Policy

Takeda And Tigenix Announce That Cx601 (Darvadstrocel) Has Received a Positive CHMP Opinion to Treat Complex Perianal Fistulas in Crohn’s Disease

This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe.

December 15, 2017
·
12 min read
Elekta Collaborates With Palabra to Offer the Industry’s Only Voice-Endable EHR

The integrated system has been installed in sites in North America and Australia.

December 15, 2017
·
2 min read
FDA

Aclaris Nabs FDA Approval for ESKATA Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs)

SKs are non-cancerous skin growths that affect more than 83 million American adults and can be an aesthetic skin concern.

December 15, 2017
·
7 min read
Business

Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results

Management to host a conference call and webcast at 8:30 a.m. eastern time today.

December 15, 2017
·
5 min read
Genetown

TESARO Announces Availability of ZEJULA (niraparib) for Women With Recurrent Ovarian Cancer in Germany

ZEJULA is the first once-daily, oral PARP inhibitor to be approved in Europe that does not require BRCA mutation or biomarker testing.

December 15, 2017
·
8 min read
Beleave Provides Business Update

The issuance of a sales license under the ACMPR is in part dependent upon the completion of a satisfactory pre-sale inspection by Health Canada.

December 15, 2017
·
2 min read
Drug Development

Espero BioPharma Provides Corporate Update and 2018 Objectives

Espero BioPharma today announced a strategic update on its clinical and regulatory strategies for tecarfarin, an oral anticoagulant.

December 15, 2017
·
6 min read
OSE Immunotherapeutics Receives a Grant From French Government Program “Fonds Unique Interministériel” to Explore New Cytotoxic Antibodies

This collaborative program is focused on developing innovative tests to explore and to measure the cytotoxicity of monoclonal antibodies.

December 15, 2017
·
4 min read